Jade Biosciences, Inc. (JBIO)
$21.33-0.05%Close
BUYCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $696M
- Avg volume
- 971.8K
- Beta
- 1.49
- P/E (TTM)
- -7.76
- Short % float
- 35.79%
- Days to cover
- 11.5
- SI change
- +15.4%
- 1W
- -9.04%
- 1M
- +6.23%
- 3M
- -3.96%
- YTD
- +50.64%
- vs SPY 1W
- -7.85%
- vs SPY 1M
- +2.90%
- vs SPY 3M
- -6.35%
- vs SPY YTD
- +38.88%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AURABUYAura Biosciences, Inc.RECOVERYQ -3$7.90+1.28%
- AVBPSELLArriVent BioPharma, Inc. Common StockRECOVERYQ 21$28.26-2.95%
- AVLNBUYAvalyn Pharma Inc. Common StockQ 75$37.69-1.77%
- CLYMBUYClimb Bio, Inc.BULLQ 11$16.40-5.09%
- COAGBUYHemab Therapeutics Holdings, Inc. Common StockQ 70$46.67-5.07%
- DFTXSELLDefinium Therapeutics, Inc.RECOVERYQ 27$43.27-3.65%
- ELDNSELLEledon Pharmaceuticals, Inc.RECOVERYQ -11$3.41-1.16%
- ELVNBUYEnliven Therapeutics, Inc.BULLQ 15$61.15+2.22%
- EPRXBUYEupraxia Pharmaceuticals Inc.RECOVERYQ 46$7.28+8.17%
- GHRSBUYGH Research PLCBEARQ 19$28.10-0.81%
- GPCRBUYStructure Therapeutics Inc.RECOVERYQ 27$49.01-0.16%
- IMMXBUYImmix Biopharma, Inc.RECOVERYQ 29$13.61-0.37%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 20
- VALUE
- 8
- GROWTH
- 47
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-29.5%
REV YoY-
ROE-49.1%
EPS YoY-
ROA-32.5%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-7.76
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B2.96
P/FCF-
EV/EBITDA-7.62
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.14
ALTMAN Z-
CURR RATIO14.93
ND/EBITDA-
BETA1.49
